Replies to post #85 on Nektar Therapeutics (NKTR)

[surf1944]

Nektar shares at a signficant discount, says Morgan Joseph
theflyonthewall

On Wednesday August 24, 2011, 9:24 am EDT

Morgan Joseph recommends buying Nektar aggressively given its strong pipeline, leadership in PEGylation technology, and sound business strategy, among other reasons. Shares are Buy rated with a $16 price target